GeneDx Holdings Corp. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.88
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.21
|
0.04
|
0.25
|
119.05%
|
|
2024-06-30
|
-0.30
|
-0.10
|
0.20
|
66.67%
|
|
2024-03-31
|
-0.67
|
-0.33
|
0.34
|
50.75%
|
|
2023-12-31
|
-0.75
|
-0.69
|
0.06
|
8.00%
|
|
2023-09-30
|
-1.31
|
-0.82
|
0.49
|
37.40%
|
|
2023-06-30
|
-1.31
|
-1.64
|
-0.33
|
-25.19%
|
|
2023-03-31
|
-2.14
|
-2.44
|
-0.30
|
-14.02%
|
|
2022-12-31
|
-0.16
|
-0.25
|
-0.09
|
-56.25%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-0.39
|
|
2023-12-31
|
-5.59
|
|
2022-12-31
|
-1.01
|
|
2021-12-31
|
-1.87
|
|
2020-12-31
|
0.00
|